Literature DB >> 16698994

Ebola virus VP35-VP40 interaction is sufficient for packaging 3E-5E minigenome RNA into virus-like particles.

Reed F Johnson1, Sarah E McCarthy, Peter J Godlewski, Ronald N Harty.   

Abstract

The packaging of viral genomic RNA into nucleocapsids and subsequently into virions is not completely understood. Phosphoprotein (P) and nucleoprotein (NP) interactions link NP-RNA complexes with P-L (polymerase) complexes to form viral nucleocapsids. The nucleocapsid then interacts with the viral matrix protein, leading to specific packaging of the nucleocapsid into the virion. A mammalian two-hybrid assay and confocal microscopy were used to demonstrate that Ebola virus VP35 and VP40 interact and colocalize in transfected cells. VP35 was packaged into budding virus-like particles (VLPs) as observed by protease protection assays. Moreover, VP40 and VP35 were sufficient for packaging an Ebola virus minigenome RNA into VLPs. Results from immunoprecipitation-reverse transcriptase PCR experiments suggest that VP35 confers specificity of the nucleocapsid for viral genomic RNA by direct VP35-RNA interactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16698994      PMCID: PMC1472164          DOI: 10.1128/JVI.01857-05

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Ebola virus VP40-induced particle formation and association with the lipid bilayer.

Authors:  L D Jasenosky; G Neumann; I Lukashevich; Y Kawaoka
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  The Ebola virus VP35 protein functions as a type I IFN antagonist.

Authors:  C F Basler; X Wang; E Mühlberger; V Volchkov; J Paragas; H D Klenk; A García-Sastre; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

3.  A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding.

Authors:  R N Harty; M E Brown; G Wang; J Huibregtse; F P Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  Morphology of Marburg virus NP-RNA.

Authors:  Manos Mavrakis; Larissa Kolesnikova; Guy Schoehn; Stephan Becker; Rob W H Ruigrok
Journal:  Virology       Date:  2002-05-10       Impact factor: 3.616

5.  Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein.

Authors:  E C Coronel; T Takimoto; K G Murti; N Varich; A Portner
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  On the domain structure and the polymerization state of the sendai virus P protein.

Authors:  N Tarbouriech; J Curran; C Ebel; R W Ruigrok; W P Burmeister
Journal:  Virology       Date:  2000-01-05       Impact factor: 3.616

7.  RNA polymerase I-driven minigenome system for Ebola viruses.

Authors:  Allison Groseth; Heinz Feldmann; Steven Theriault; Gülsah Mehmetoglu; Ramon Flick
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

8.  Analysis of Ebola virus and VLP release using an immunocapture assay.

Authors:  George Kallstrom; Kelly L Warfield; Dana L Swenson; Shannon Mort; Rekha G Panchal; Gordon Ruthel; Sina Bavari; M Javad Aman
Journal:  J Virol Methods       Date:  2005-04-25       Impact factor: 2.014

9.  Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP.

Authors:  Takeshi Noda; Hiroshi Sagara; Emiko Suzuki; Ayato Takada; Hiroshi Kida; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

10.  The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein.

Authors:  Yue Huang; Ling Xu; Yongnian Sun; Gary J Nabel
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

View more
  33 in total

1.  Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography.

Authors:  Tanmay A M Bharat; Takeshi Noda; James D Riches; Verena Kraehling; Larissa Kolesnikova; Stephan Becker; Yoshihiro Kawaoka; John A G Briggs
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

2.  Viral and host proteins that modulate filovirus budding.

Authors:  Yuliang Liu; Ronald N Harty
Journal:  Future Virol       Date:  2010-07-01       Impact factor: 1.831

3.  Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function.

Authors:  Kathleen C Prins; Jennifer M Binning; Reed S Shabman; Daisy W Leung; Gaya K Amarasinghe; Christopher F Basler
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

4.  Ebolavirus VP35 is a multifunctional virulence factor.

Authors:  Daisy W Leung; Kathleen C Prins; Christopher F Basler; Gaya K Amarasinghe
Journal:  Virulence       Date:  2010-11-01       Impact factor: 5.882

Review 5.  Conformational plasticity of the Ebola virus matrix protein.

Authors:  Jens Radzimanowski; Gregory Effantin; Winfried Weissenhorn
Journal:  Protein Sci       Date:  2014-09-04       Impact factor: 6.725

6.  Mapping of the VP40-binding regions of the nucleoprotein of Ebola virus.

Authors:  Takeshi Noda; Shinji Watanabe; Hiroshi Sagara; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

7.  Ebolavirus VP35 coats the backbone of double-stranded RNA for interferon antagonism.

Authors:  Shridhar Bale; Jean-Philippe Julien; Zachary A Bornholdt; Alexander S Krois; Ian A Wilson; Erica Ollmann Saphire
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

8.  Filovirus replication and transcription.

Authors:  Elke Mühlberger
Journal:  Future Virol       Date:  2007-03       Impact factor: 1.831

9.  The Ebola virus protein VP40 hexamer enhances the clustering of PI(4,5)P2 lipids in the plasma membrane.

Authors:  Jeevan B Gc; Bernard S Gerstman; Robert V Stahelin; Prem P Chapagain
Journal:  Phys Chem Chem Phys       Date:  2016-10-19       Impact factor: 3.676

10.  Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35.

Authors:  Daisy W Leung; Kathleen C Prins; Dominika M Borek; Mina Farahbakhsh; JoAnn M Tufariello; Parameshwaran Ramanan; Jay C Nix; Luke A Helgeson; Zbyszek Otwinowski; Richard B Honzatko; Christopher F Basler; Gaya K Amarasinghe
Journal:  Nat Struct Mol Biol       Date:  2010-01-17       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.